← Back to Vaccine Database

BNT162a1

RNA based vaccine · VDDBV0127

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
Covid19; Severe Acute Respiratory Syndrome
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04380701 Phase 2Covid19; Severe Acute Respiratory Syndrome